Cohort study demonstrates enhanced substrate mapping resolution in patients with scar-related ventricular tachycardia, indicating potential improvements in ablation targeting.
– A partial delineation of targets for ablation of ventricular tachycardia (VT) during a stable rhythm is likely responsible for a suboptimal success rate. The abnormal low-voltage near-field functional components may be hidden within the high-amplitude far-field signal. We aim to evaluate the benefit and feasibility of functional substrate mapping using a full ventricle S3 protocol and to assess its colocalization with conducting channels (CCs) in the late gadolinium enhancement cardiac magnetic resonance (LGE-CMR). – An S3 mapping protocol with a drive train of S1 followed by S2 (effective refractory period (ERP) +30ms) and S3 (ERP+50ms) from the RV apex was performed in 40 consecutive patients undergoing scar-related VT ablation. Deceleration zones (DZs) and areas of late potentials (LPs) were identified for all maps. A pre-procedural non-invasive substrate assessment was done with LGE-CMR and post-processing with automated CCs identification. – The S3 protocol was completed in 34 of the 40 procedures (85.0%). The S3 protocol enhanced the identification of VT isthmus based on DZs (89% vs. 62%, p<0.01) and LPs assessment (93% vs. 78%, p=0.04). The percentage of CCs unmasked by DZs and LPs using S3 maps was significantly higher than the ones using S2 and S1 maps (78%, 65%, and 48%; p<0.001, and 88%, 81%, and 68%; p<0.01, repectively). The functional substrate identified during the S3 activation mapping was significantly more extensive than the one identified using S2 and S1, including a higher number of DZs (2.94, 2.47, and 1.82, respectively; p<0.001), and a wider area of LPs (44.1, 38.2, and 29.4cm2, respectively; p<0.001). After VT ablation, 77.9% of patients have been VT free during a median follow-up of 13.6 months. – The S3 protocol is feasible in 85% of patients, allows for a better identification of targets for ablation, and may potentially improve VT ablation results.
No takes yet. Share an insight, caveat, or question.
Guichard et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: